On September 10, 2020 Fresenius Medical Care, the world’s leading provider of dialysis products and services,reported that it has agreed to issue bonds with an aggregate principal amount of USD 1 billion (Press release, Fresenius, SEP 10, 2020, View Source [SID1234564918]). The bonds will mature in February 2031 and have an annual coupon of 2.375%. The issue price is 99.699%, resulting in a yield of 2.408%.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The proceeds will be used for general corporate purposes, including the refinancing of outstanding indebtedness.

The expected settlement date is September 16, 2020.